Beximco Pharmaceuticals Limited announced earnings results for the third quarter ended March 31, 2020. For the third quarter, the company announced sales was BDT 6,610.063 million compared to BDT 5,756.571 million a year ago. Operating income was BDT 1,473.961 million compared to BDT 1,244.814 million a year ago. Net income was BDT 900.434 million compared to BDT 747.193 million a year ago. Basic earnings per share was BDT 2.22 compared to BDT 1.84 a year ago. For the nine months, sales was BDT 19,105.589 million compared to BDT 16,866.369 million a year ago. Operating income was BDT 4,231.855 million compared to BDT 3,729.957 million a year ago. Net income was BDT 2,626.880 million compared to BDT 2,235.596 million a year ago. Basic earnings per share was BDT 6.48 compared to BDT 5.51 a year ago.